IP Verse

Puren Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Puren Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3578175	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Aug 29, 2023
EP3578173	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Jul 26, 2023
EP3260117	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	May 25, 2021
EP3342411	Rapamycin Derivative For Treating Pancreas Cancer	NOVARTIS	Apr 29, 2020

Explore the latest publications and patents granted to Puren Pharma, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Puren Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Puren Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
PUREN PHARMA	3	-	-	-
AMGEN	8	138	8	11
EURO CELTIQUE	-	44	-	-
NOVARTIS	6	422	-	21